Fig. 1
From: Prevention and control of non-communicable diseases in iran: the case for Investment
Structure of the economic burden of NCDs in Iran, 2018. The shares of direct and indirect costs of four NCD groups was estimated. Direct cost represent the highest percentage (51) in health expenditure in Iran